QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 6 filers reported holding QIAGEN NV in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $5,521,000 | +5.0% | 195,467 | +2.1% | 0.03% | 0.0% |
Q3 2016 | $5,256,000 | +24.3% | 191,381 | -2.0% | 0.03% | +13.8% |
Q2 2016 | $4,230,000 | +34.8% | 195,350 | +37.8% | 0.03% | +26.1% |
Q1 2016 | $3,137,000 | -17.4% | 141,780 | +2.9% | 0.02% | -20.7% |
Q4 2015 | $3,800,000 | +6.5% | 137,723 | -0.2% | 0.03% | -3.3% |
Q3 2015 | $3,569,000 | -2.9% | 138,003 | -7.0% | 0.03% | +15.4% |
Q2 2015 | $3,676,000 | +9.9% | 148,313 | +11.7% | 0.03% | +13.0% |
Q1 2015 | $3,346,000 | -90.6% | 132,793 | -91.3% | 0.02% | -91.6% |
Q4 2014 | $35,484,000 | -1.1% | 1,519,730 | -3.4% | 0.28% | -3.2% |
Q3 2014 | $35,878,000 | -7.0% | 1,572,995 | -1.3% | 0.28% | -3.7% |
Q2 2014 | $38,594,000 | +15.0% | 1,594,076 | -0.3% | 0.30% | +8.5% |
Q1 2014 | $33,574,000 | -11.9% | 1,598,803 | -1.9% | 0.27% | -14.7% |
Q4 2013 | $38,129,000 | +56.0% | 1,629,503 | +38.1% | 0.32% | +49.1% |
Q3 2013 | $24,441,000 | +13.4% | 1,180,199 | +9.0% | 0.21% | -1.8% |
Q2 2013 | $21,556,000 | – | 1,082,991 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |